242
Participants
Start Date
November 22, 2018
Primary Completion Date
November 22, 2024
Study Completion Date
November 22, 2027
Fludarabine
IV
Melphalan
IV
Alemtuzumab
IV
Cyclophosphamide
IV
Mesna
IV
Total Body Irradiation (8Gy)
TBI (8Gy)
Heart of England Nhs Foundation Trust, Birmingham
University Hospitals Birmingham Nhs Foundation Trust, Birmingham
Central Manchester University Hospitals Nhs Foundation Trust, Manchester
The Newcastle Upon Tyne Hospitals Nhs Foundation Trust, Newcastle
University Hospitals Bristol Nhs Foundation Trust, Bristol
Cambridge University Hospitals Nhs Foundation Trust, Cambridge
Cardiff and Vale University Health Board, Cardiff
NHS Greater Glasgow and Clyde, Glasgow
Leeds Teaching Hospitals Nhs Trust, Leeds
University Hospitals of Leicester Nhs Trust, Leicester
The Clatterbridge Cancer Centre Nhs Foundation Trust, Liverpool
Barts Health Nhs Trust, London
University College London Hospitals Nhs Foundation Trust, London
Kings College Hospital, London
The Royal Marsden Nhs Foundation Trust, London
Imperial College Healthcare Nhs Trust, London
The Christie Nhs Foundation Trust, Manchester
Nottingham University Hospitals Nhs Trust, Nottingham
Oxford University Hospitals Nhs Foundation Trust, Oxford
Plymouth Hospitals Nhs Trust, Plymouth
Sheffield Teaching Hospitals Nhs Foundation Trust, Sheffield
University Hospital Southampton Nhs Foundation Trust, Southampton
University of Birmingham
OTHER